Xolair on Humana Basic Rx Plan (S5884-109)
omalizumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 4 per 28 days.
$1,475.21
Patient pays / month, after deductible
$1,936.46
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
XOLAIR PFS 75 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $5,900.84 for a month. Other covered strengths are listed below.
Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| XOLAIR PFS 75 mg/.5mL Injection, Solution | 5 | $1,479.64 | PA · 4 per 28 days |
| XOLAIR PFS 75 mg/.5mL Injection, Solution | 5 | $1,475.21 | PA · 4 per 28 days |
| XOLAIR PFS 150 mg/mL Injection, Solution | 5 | $3,331.95 | PA · 8 per 28 days |
| XOLAIR PFS 150 mg/mL Injection, Solution | 5 | $3,338.64 | PA · 8 per 28 days |
| XOLAIR 300 mg/2mL Injection, Solution | 5 | $3,329.11 | PA · 8 per 28 days |
| XOLAIR 300 mg/2mL Injection, Solution | 5 | $3,323.87 | PA · 8 per 28 days |
Other Asthma and COPD biologics on this plan
Verify with the plan before prescribing or filling. Member services: (800)281-6918. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5884-109